Zymeworks BC Inc’s recent filing unveils that its Director EcoR1 Capital, LLC acquired Company’s shares for reported $2.68 million on Jan 10 ’25. In the deal valued at $13.13 per share,204,098 shares were bought. As a result of this transaction, EcoR1 Capital, LLC now holds 15,411,078 shares worth roughly $203.73 million.
Then, EcoR1 Capital, LLC bought 21,021 shares, generating $295,829 in total proceeds. Upon buying the shares at $14.07, the Director now owns 15,206,980 shares.
Before that, Moore Paul Andrew sold 21,200 shares. Zymeworks BC Inc shares valued at $316,391 were divested by the Chief Scientific Officer at a price of $14.92 per share. As a result of the transaction, Moore Paul Andrew now holds 14,741 shares, worth roughly $0.19 million.
JP Morgan upgraded its Zymeworks BC Inc [ZYME] rating to an Overweight from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who increased its forecast for the stock in early November from “a Market perform” to “an Outperform”. Wells Fargo also remained covering ZYME and has decreased its forecast on November 01, 2024 with a “an Equal weight” recommendation from previously “an Overweight” rating.
Price Performance Review of ZYME
On Friday, Zymeworks BC Inc [NASDAQ:ZYME] saw its stock fall -6.44% to $13.22. Over the last five days, the stock has lost -10.55%. Zymeworks BC Inc shares have fallen nearly -9.70% since the year began. Nevertheless, the stocks have risen 14.96% over the past one year. While a 52-week high of $17.70 was reached on 01/03/25, a 52-week low of $7.97 was recorded on 01/10/25. SMA at 50 days reached $14.43, while 200 days put it at $11.35.
Levels Of Support And Resistance For ZYME Stock
The 24-hour chart illustrates a support level at 12.76, which if violated will result in even more drops to 12.30. On the upside, there is a resistance level at 13.81. A further resistance level may holdings at 14.40. The Relative Strength Index (RSI) on the 14-day chart is 40.11, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.41, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 87.50%. Stochastics %K at 28.13% indicates the stock is a holding.
How much short interest is there in Zymeworks BC Inc?
A steep rise in short interest was recorded in Zymeworks BC Inc stocks on 2024-12-13, growing by 0.13 million shares to a total of 4.34 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 4.21 million shares. There was a rise of 3.0%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on January 04, 2023 when H.C. Wainwright resumed its ‘”a Neutral”‘ rating for the stock and retained the price target to $8.
